Glucose transporters as markers of diagnosis and prognosis in cancer diseases

41Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

The primary metabolic substrate for cells is glucose, which acts as both a source of energy and a substrate in several processes. However, being lipophilic, the cell membrane is impermeable to glucose and specific carrier proteins are needed to allow transport. In contrast to normal cells, cancer cells are more likely to generate energy by glycolysis; as this process generates fewer molecules of adenosine triphosphate (ATP) than complete oxidative breakdown, more glucose molecules are needed. The increased demand for glucose in cancer cells is satisfied by overexpression of a number of glucose transporters, and decreased levels of others. As specific correlations have been observed between the occurrence of cancer and the expression of glucose carrier proteins, the presence of changes in expression of glucose transporters may be treated as a marker of diagnosis and/or prognosis for cancer patients.

Cite

CITATION STYLE

APA

Szablewski, L. (2022). Glucose transporters as markers of diagnosis and prognosis in cancer diseases. Oncology Reviews. Page Press Publications. https://doi.org/10.4081/oncol.2022.561

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free